Human Mesenchymal Stem Cells Prevent Neurological Complications of Radiotherapy by Soria Escoms, Bernat et al.
fncel-13-00204 May 15, 2019 Time: 17:34 # 1
ORIGINAL RESEARCH




University of Valencia, Spain
Reviewed by:
Munjal M. Acharya,
University of California, Irvine,
United States
Rachel Sarabia Estrada,








This article was submitted to
Cellular Neurophysiology,
a section of the journal
Frontiers in Cellular Neuroscience
Received: 31 January 2019
Accepted: 24 April 2019
Published: 16 May 2019
Citation:
Soria B, Martin-Montalvo A,
Aguilera Y, Mellado-Damas N,
López-Beas J, Herrera-Herrera I,
López E, Barcia JA,
Alvarez-Dolado M, Hmadcha A and
Capilla-González V (2019) Human
Mesenchymal Stem Cells Prevent
Neurological Complications
of Radiotherapy.
Front. Cell. Neurosci. 13:204.
doi: 10.3389/fncel.2019.00204
Human Mesenchymal Stem Cells
Prevent Neurological Complications
of Radiotherapy
Bernat Soria1,2, Alejandro Martin-Montalvo1, Yolanda Aguilera1, Nuria Mellado-Damas1,
Javier López-Beas1, Isabel Herrera-Herrera3, Escarlata López4, Juan A. Barcia5,
Manuel Alvarez-Dolado1, Abdelkrim Hmadcha1,2* and Vivian Capilla-González1*†
1 Department of Regeneration and Cell Therapy, Andalusian Center for Molecular Biology and Regenerative Medicine
(CABIMER), University of Pablo de Olavide – University of Seville, CSIC, Seville, Spain, 2 Centro de Investigación Biomédica
en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain, 3 Department of Neuroradiology,
Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain, 4 Department of Radiation Oncology, Hospital Universitario
Fundación Jiménez Díaz, Madrid, Spain, 5 Service of Neurosurgery, Hospital Clínico San Carlos, Instituto de Investigación
Sanitaria San Carlos (IdISSC), Department of Surgery, Universidad Complutense de Madrid, Madrid, Spain
Radiotherapy is a highly effective tool for the treatment of brain cancer. However,
radiation also causes detrimental effects in the healthy tissue, leading to neurocognitive
sequelae that compromise the quality of life of brain cancer patients. Despite the
recognition of this serious complication, no satisfactory solutions exist at present.
Here we investigated the effects of intranasal administration of human mesenchymal
stem cells (hMSCs) as a neuroprotective strategy for cranial radiation in mice. Our
results demonstrated that intranasally delivered hMSCs promote radiation-induced
brain injury repair, improving neurological function. This intervention confers protection
against inflammation, oxidative stress, and neuronal loss. hMSC administration reduces
persistent activation of damage-induced c-AMP response element-binding signaling
in irradiated brains. Furthermore, hMSC treatment did not compromise the survival
of glioma-bearing mice. Our findings encourage the therapeutic use of hMSCs as a
non-invasive approach to prevent neurological complications of radiotherapy, improving
the quality of life of brain tumor patients.
Keywords: radiotherapy, stem cells, cognition, neuroprotection, intranasal cell delivery, CREB, neurocognitive
sequelae, brain cancer
INTRODUCTION
Radiotherapy is one of the most common treatments for cancer. Around 50% of all tumor
patients receive radiation at a given time (Delaney et al., 2005). Unfortunately, radiotherapy
comes with short and long term side effects. In particular, radiation for brain tumors, the most
common cancer in children (Ostrom et al., 2016), causes accelerated aging that is manifested
as neurofunctional sequelae, which may be progressive and permanent (Douw et al., 2009;
Marazziti et al., 2012; Padovani et al., 2012; Armstrong et al., 2013; Ma et al., 2017). The
most frequently described adverse effects of cranial radiation include learning and memory
difficulties, problems in executive functions, motor coordination, visual alterations and intellectual
decline. These radiation-related sequelae compromise the quality of life of cancer survivors
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and represent a serious clinical problem with no satisfactory
solutions at present.
Studies in brain cancer patients and rodent evidences that
radiation-related neurofunctional sequelae are associated with
a variety of anatomical changes that occur in the irradiated
non-tumoral tissue (Makale et al., 2017). Immediately after
radiation, brain exhibits vascular damages, oligodendrocyte
loss, demyelination and neuroinflammation. Radiation-induced
brain injury also disrupts the neurogenic niches located
at the dentate gyrus (DG) of the hippocampus and the
subventricular zone (SVZ) of the lateral ventricles. Moreover,
brain injury also affects neuronal dendritic spines and white
matter, leading to necrosis of specific areas. The discovery
of the negative effects induced by radiation in the non-
tumoral tissue has promoted the development of strategies
to minimize radiotherapy side effects. In this context, stem
cell-based therapy represents a novel alternative to attenuate
radiation-induced brain injury (Acharya et al., 2011, 2015;
Joo et al., 2012; Piao et al., 2015). In this line, Joo et al.
(2012) described the benefits of supplementing whole-brain
irradiated mice with fetal mouse neural stem cells (NSCs),
which were injected via tail vein 24 h after radiation. The
irradiated brain induced homing of the exogenous NSCs, which
differentiated along glial and neuronal lineages. Two months after
NSC administration, mice showed inhibited radiation-induced
hippocampus atrophy and preserved short-term memory.
Similarly, human embryonic stem cell-derived oligodendrocyte
progenitors (hOPCs) have provided promising results. After
bilateral injections into the corpus callosum of rats, hOPCs
were able to remyelinate the brain and ameliorate radiation-
induced cognitive dysfunction (Piao et al., 2015). However, stem
cell-based therapies proposed in current studies present some
restrictions that need to be solved if translation to human
is sought (Ramos-Zuriga et al., 2012). First, several studies
used stem cells with scarce availability and whose isolation
procedure is highly invasive (e.g., NSCs). Second, the routes
used for administration have limited effectiveness (e.g., systemic
transplantation renders reduced concentration of transplanted
cells in the brain) or requires invasive techniques that risk
host safety (e.g., intracranial injections). Here we explored
the non-invasive intranasal delivery of human mesenchymal
stem cells (hMSCs) derived from adipose tissue to prevent
radiation-induced brain damage in a mouse model of whole-
brain radiation. Our results demonstrated that transplanted
hMSCs promoted neuroprotection and improved neurological




Two-month-old male C57BL/6 mice were purchased from
Charles River Laboratories (Barcelona, Spain). For cell
transplant, two-month-old male immunodeficient athymic
nude mice (Charles River Laboratories) were used to
maximize the non-rejection and survival of transplanted
cells. Experimental groups were randomly assigned. Mice were
housed in a specific pathogen free animal facility. Animals
were maintained on a 12-h light/dark cycle, with stable
temperature (22◦C) and humidity (60%), and with food and
water available ad libitum.
X-Ray Irradiation
Mice were anesthetized via intraperitoneal injection of a
combination of 100 mg/kg ketamine and 10 mg/kg xylazine.
Then, animals were positioned in a prone position in the
X-ray irradiation device (MBR-1505R; Hitachi, Tokyo, Japan)
for head-only irradiation, as described elsewhere (Suarez-
Pereira et al., 2015). Animals were irradiated at 160 kV
and 6.3 mA with a lead shield covering the entire body,
excluding the head. A total dose of 10 Gy in 2 fractions
(2 × 5 Gy) was delivered at a source-to-skin distance of 33 cm.
Control animals were littermates handled similarly and did not
receive radiation.
hMSC Culture
Human mesenchymal stem cell (ATCC, PCS-500-011TM;
see Supplementary Table 1 for cell lines information)
were cultured in growth media composed of Dulbecco’s
Modified Eagle Medium (DMEM; Life Technologies, Carlsbad,
CA) supplemented with 10% fetal bovine sera and 1%
penicillin-streptomycin, and incubated at 37◦C in a 20%
O2 and 5% CO2 humidified atmosphere. Media were changed
every 2–3 days. For all experiments, hMSCs were used at
passage 4–7. The ability of hMSCs to generate multiple lineages
and express established MSC markers was previously verified
(Capilla-Gonzalez et al., 2018).
hMSC Transplantation and
Biodistribution
Human mesenchymal stem cell treatment was initiated the day
after radiation. Briefly, animals were anesthetized and placed in a
supine position to administrate total of 100 U of hyaluronidase
as 2 repeated inoculations in each nostril with 5-min intervals
(3 µl per inoculation). After 30 min, 5 × 105 of hMSCs in
PBS were delivered as 2 repeated inoculations in each nostril
with 5-min intervals (3 µl per inoculation). Mice received a
dose of cells per week during 4 consecutive weeks. Control mice
received hyaluronidase followed by PBS. For evaluation of cell
biodistribution, cultured hMSCs were incubated with 400 µg/mL
XenoLight DiR fluorescent dye (Perkin Elmer, Inc., Boston, MA)
for 30 min at 37◦C before transplantation. Transplanted mice
were daily monitored using an IVIS Imaging System 200 Series
(Caliper Life Science, Hopkinton, MA).
Behavioral Tests
Neurological function was tested between day 33 and day 44
post-radiation using a battery of behavioral tests, following
previously described protocols. First, motor coordination was
evaluated by rotarod performance (Lopez-Noriega et al., 2017)
on days 33–34. Second, muscle strength was evaluated by
the wirehang test (Klein et al., 2012) on day 35. Third,
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olfaction was evaluated by measuring odor discrimination
capacity in a two-odorants test (habituation-dishabituation test)
(Capilla-Gonzalez et al., 2012) on day 37. Finally, cognition was
assessed by performing the novel object recognition task with a
long habituation phase, using odorless objects that do not retain
any olfactory cues (Leger et al., 2013), on days 40–44.
Microarray
RNA was isolated from the brain lateral ventricle (PLv)
and the hippocampus (Hipp) using the RNeasy Mini Kit
(Qiagen, Hilden, Germany). 100 ng of RNA was used to
obtain the gene expression profile of each sample. All samples
showed the characteristics of high-quality RNA and were
subjected to subsequent analysis. cDNA was hybridized to
the ClariomTM S Assay Mouse Array (Affymetrix, Santa
Clara, CA) using manufacturer’s protocol (Affymetrix,
GeneChip WT PLUS). Microarrays were scanned using the
GeneChip Scanner 3000 7G of Affymetrix. Data processing
and statistical analysis was performed using Transcriptome
Analysis Console (TAC) software from Affymetrix, using
default parameters. Canonical pathway analysis was performed
using Ingenuity Pathway Analysis (IPA) software from Qiagen.
Venn diagrams were generated using the open-source online
tool Venny 2.1.0. Microarray data are deposited in Gene
Expression Omnibus (GEO) database repository (accession
number: GSE115735).
Western Blots
Dissected PLv and Hipp were lysed for protein extraction
using RIPA buffer (Sigma-Aldrich, Madrid, Spain), containing
0.5% sodium deoxycholate, 1 mM PMSF, 2 mM EDTA, 1×
protease inhibitor (Roche Diagnostics, Mannheim, Germany)
and 1× phosphatase inhibitor cocktail (Thermo Fisher Scientific,
Madrid, Spain). Proteins from whole tissue lysates (25 µg)
were resolved using 10% Tris-Glycine gel electrophoresis, and
transferred onto nitrocellulose membranes (Whatman, Dassel,
Germany). Membranes were then blocked with 5% non-fat
milk and primary antibodies were probed (see Supplementary
Table 1 for antibody information). Detection was done with the
appropriate horseradish-peroxidase conjugated secondary
antibodies and using the enhanced chemiluminescence
reagent (GE Healthcare Life Sciences, Buckinghamshire,
United Kingdom). Densitometric analyses for the blots were
performed using ImageJ software (version 1.4r; National Institute
of Health, Bethesda, MD) and normalized to Ponceau S staining
or GAPDH expression.
Brain Tissue Fixation
Mice were anesthetized and subjected to intracardiac perfusion
using a peristaltic pump. As a fixative, 2% paraformaldehyde
and 2.5% glutaraldehyde was used for electron microscopy, while
4% paraformaldehyde was used for immunohistochemistry.
Brains were removed and post-fixed in the same fixative
solution overnight.
Transmission Electron Microscopy
Fixed brains were rinsed in 0.1 M phosphate buffer (PB)
and cut into 200 µm sections using a VT 1000M vibratome
(Leica, Wetzlar, Germany). Sections were postfixed in 2%
osmium tetroxide, dehydrated in ethanol, stained in 2% uranyl
acetate and embedded in araldite (Durcupan, Fluka BioChemika,
Ronkokoma, NY). Ultrathin sections (60–70 nm) were cut with
a diamond knife, stained with lead citrate, and examined under
a Spirit transmission electron microscope (FEI Tecnai, Hillsboro,
OR) (Capilla-Gonzalez et al., 2010).
Immunohistochemistry
Fixed brains were rinsed in 0.1 M phosphate buffer (PB) and cut
into serial 10 µm thick sections using a CM 3050S cryostat (Leica,
Mannheim, Germany). Sections were incubated in blocking
solution for 1 h at room temperature, followed by overnight
incubation at 4◦C with primary antibodies (see Supplementary
Table 1 for antibody information). Then, sections were washed
and incubated with the appropriate secondary antibodies
conjugated with fluorophores and examined under a Leica
DM6000B microscope or Leica TC5 SP5 confocal microscope and
imaged with the Leica Application Suite software. Fluorescence
signal was quantified using ImageJ or MetaMorph software
(Molecular Devices, San Jose, CA).
Brain Tumor Model
To investigate the side effects effect of transplanting hMSCs into
mice bearing a brain tumor, 7-weeks-old male immunodeficient
athymic nude mice were stereotactically injected with 0.5 × 106
glioma cells (U87MG; ATCC, HTB-14TM; see Supplementary
Table 1 for cell lines information) into the right striatum (A:
0.5, L: 2.0, D: 3.5). The stereotactic surgery procedure was done
as previously described (Capilla-Gonzalez et al., 2014). Prior
transplantation, glioma cells were labelled with the XenoLight
DiR fluorescent dye, following the same protocol described
for hMSCs labeling. The days after cell transplant, mice were
imaged using an IVIS Imaging System 200 Series (Caliper Life
Science, Hopkinton, MA) to ensure that grafted cells form
a tumor. Ten days after tumor cell injection, animals were
randomly distributed into three groups: mice bearing a brain
tumor (n = 11), mice bearing a brain tumor that received
radiation (n = 11), and mice bearing a brain tumor that
received radiation and hMSCs (n = 12). Radiation and hMSC
transplant were given as described above. Mice were euthanized
when the condition of the animal was considered incompatible
with continued survival. Survival curves were plotted using the
Kaplan–Meier method, which include any animal found dead
or euthanized. Histopathological analysis of brains at time of
death was performed on cryosections stained with hematoxylin
and eosin method.
Statistical Analysis
Data were expressed as mean ± SEM. Data were analyzed using
the GraphPad Prism 7 software (GraphPad Software Inc., San
Diego, CA) and SigmaPlot 12.0 software (Jandel Scientific, San
Rafael, CA). The t-test was performed to compare two means,
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while ANOVA was performed to compare more than two means.
Repeated-measures ANOVA and Multiple t-test were applied
when appropriated. Log-rank test was performed to determine
differences in survival. All differences were considered significant
at a p value<0.05.
RESULTS
Radiation Induces Anatomical Changes
in the Mouse Brain
To characterize the impact of radiation in mouse brain, two
month-old C57BL/6 mice were subjected to whole-brain
radiation (total dose of 10 Gy). The histopathological analysis
of mouse brain tissue by electron microscopy revealed
frequent necrotic cells and microglia 30 days post-radiation
(Figures 1A–C). Microglia staining to detect Iba1 expression
evidenced bushy microglia (activated cells) in the irradiated
brain that manifested an inflammatory state, while the
non-irradiated brain displayed more ramified microglia
(resting cells) (Figures 1D–E). Furthermore, NSCs residing
in the irradiated brain frequently presented envelope-limited
chromatin sheets (i.e., quiescent NSCs), while NSCs in the
non-irradiated brain often displayed condensed chromosomes
associated with an early prophase (i.e., active NSCs) (Figure 1F).
This observation was in line with the reduced proliferation (Ki67
staining) and scarce newly born neurons (DCX, doublecortin
staining) in the DG and SVZ after radiation, while the NSC
marker nestin showed no evident differences (Figures 1G–J).
hMSCs Reached the Brain After
Intranasal Administration
To validate that the intranasal route is a feasible via to deliver cells
to the brain, XenoLight DiR-labeled hMSCs were administrated
into the nostrils of athymic nude mice (a dose of cells per
week during 4 consecutive weeks) (Supplementary Figure 1).
A cohort of animals was injected with PBS as control group.
Biodistribution analysis revealed that 2 h after the first dose
of cells, fluorescence was restricted to the head, becoming
maximal at day 1 and then tending to gradually decrease within
the following 6 days (Figures 2A,B). However, the repeated
doses of cells presented a cumulative effect that allowed to
prolong fluorescence signal over time (Supplementary Figure 1).
Temporary fluorescence signal was observed in the peritoneal
region 24 h after cell delivery (Supplementary Figure 1). No
signal was observed in mice treated with PBS at any time
point. In order to demonstrate the presence of hMSCs in
the brain, a group of mice was sacrificed the day after cell
administration and brains were dissected. Fluorescence signal
was detected in the olfactory bulbs and frontal lobes (Figure 2C).
To analyze whether hMSCs persist into the brain on day
50, immunofluorescence against human-specific mitochondria
(hMito) and human-specific nuclei (hNuclei) was performed in
brain sections. Immunostaining revealed the presence of some
human cells at different levels of the rostrocaudal brain axis
(Supplementary Figure 1). Necropsies did not reveal any visible
FIGURE 1 | Radiation induces anatomical changes in the mouse brain.
Representative images of radiation-induced damages in the mouse brain
30 days post-radiation (total dose of 10 Gy). (A) Electron microscopy
micrograph showing multiple pyknotic cells (yellow) and microglia (red) in the
irradiated brain, compared to non-irradiated mice. (B) High magnification of a
pyknotic cell in the irradiated brain. (C) High magnification of a microglia cell in
the irradiated brain displaying round shape and abundant dense bodies
(arrows) in the cytoplasm. (D) Immunofluorescence against Iba1 reveals the
presence of ramified microglia (resting cells) in the non-irradiated brain and
bushy microglia (activated cells) in the irradiated brain. (E) Quantification of the
number of branches and total length of processes (skeletonized outgrowth) in
Iba1 expressing cells. (F) Representative images showing the presence of a
NSC with condensed chromosomes (chr) in the non-irradiated SVZ and a
quiescent NSC identified by the presence of envelope-limited chromatin
sheets (arrows) in the irradiated SVZ. (G) Immunofluorescence against Ki67,
Nestin, and DCX in the irradiated DG. (H) Immunofluorescence against Ki67,
Nestin, and DCX in the irradiated SVZ. (I) Quantification of Ki67+ cells in the
DG. (J) Quantification of Ki67+ cells in the SVZ. IR, irradiated mice; NonIR,
non-irradiated mice. Scale bar: (A) 10 µm, (B,C) 2 µm, (D) 50 µm, (F) 2 µm,
(G) 25 µm, (H) 200 µm. Data are represented as mean ± SEM. n = 5 per
group, ∗p < 0.05, ∗∗∗∗p < 0.0001; t-test.
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FIGURE 2 | Transplanted hMSCs improved neurological function after whole-brain radiation. (A) Representative images showing in vivo fluorescence signal in the
head at 2 h, 1 day, 2 days, and 6 days after the first intranasal cell delivery (5 × 105 hMSCs). (B) Quantification of the in vivo fluorescence signal in the head within
the first 6 days post transplantation, compared to day 0 (2 h after hMSC delivery). (C) In vivo fluorescence signal in dissected brains 1 day after intranasal delivery of
hMSCs. (D) Schematic representation of the study design. Mice received whole-brain radiation (total dose of 10 Gy). Twenty-four hours after radiation, 5 × 105 cells
hMSCs were administered intranasally once per week for 4 weeks. Then, mice were tested in a behavioral test battery (Rotarod, Rd on days 33–34; Wirehang, Wh
on day 35; Odor discrimination task, OD on day 37; Novel Object Recognition test, OR on days 40–44) before being sacrificed. (E) Body weight during the course of
the experiment revealing a temporary weight loss in irradiated mice (receiving or not hMSCs) the week after radiation exposure. (F) Rotarod test performance
showing an improvement in IR+MSC mice, as compared to IR mice. (G) Wirehang test performance showing no differences between any experimental group.
(H) Time spent sniffing the stimuli (Odor A and Odor B) in an odor discrimination task. (I) Discrimination index of Odor A and Odor B (presentation 6 vs. presentation
7), showing a rescued OD performance in IR+MSC mice. (J) Exploration time of the familiar object in the Novel Object Recognition test. (K) Exploration time of the
novel object in the Novel Object Recognition test. (L) Discrimination index between familiar and novel object, showing a rescued OR performance in IR+MSC mice.
Data are represented as mean ± SEM. n = 3 per group (B), n = 10–15 per group (E–L). Comparisons of IR or IR+MSC versus Non-IR are indicated with ∗.
Comparisons of IR+MSC versus IR are indicated with #. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, ####p < 0.0001; One-way ANOVA (B,F,G,I–L),
Two-way repeated-measures ANOVA (E,H). Rainbow color scale: red indicates highest fluorescence signal and blue indicates lowest fluorescence signal.
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tumor mass in mice transplanted with hMSCs 50 days after the
first cell dose. These results indicate that intranasal delivery is a
feasible route to administrate cells to the brain.
Transplanted hMSCs Improved
Neurological Function After Whole-Brain
Radiation
We then examined whether intranasally delivered hMSCs could
ameliorate neurological function in whole-brain irradiated mice.
For this, animals were randomly assigned to three experimental
groups: Non-irradiated mice receiving PBS (NonIR), irradiated
mice receiving PBS (IR) and irradiated mice receiving hMSCs
(IR+MSC). hMSC treatment (a dose of cells per week during 4
consecutive weeks) was initiated 24 h after radiation (Figure 2D).
First, body weight was monitored during the course of the
experiment (Figure 2E) as indicative of animal health status. We
found a significant weight loss the week after radiation in IR and
IR+MSC mice that was rapidly recovered, reaching the values
of NonIR animal by 2-weeks post-irradiation. Then, animals
were subjected to serial behavior testing to evaluate motor
coordination (rotarod), muscle strength (wirehang), olfaction
(odor discrimination task; OD) and cognition (novel object
recognition test; OR). The IR group showed poor rotarod
performance, as compared to NonIR and IR+MSC mice
(Figure 2F). Wirehang performance was not different between
any experimental group, indicating that results from rotarod
were not influenced by muscle strength (Figure 2G). Then,
mice were subjected to OD test. IR mice showed impaired
ability to discriminate between two odorants, as compared to the
Non-IR group, while hMSC treatment rescued OD performance
(Figures 2H,I). Finally, mice were tested to the OR task.
Exploration time of the familiar object was not different between
any experimental groups, while exploration time of the novel
object was reduced in IR mice, as compared to the other groups
(Figures 2J,K). The discrimination index indicated that both,
NonIR and IR+MSC mice exhibited a similar preference for
the novel object (Figure 2L). These observations demonstrated
a robust effect of hMSC treatment on neurofunctional recovery
after radiation.
The Gene Expression Profile of the
Irradiated Brain Was Modulated by
hMSC Transplantation
After behavioral testing (i.e., at day 50 post-radiation; Figure 2D),
all mice were sacrificed and brain tissue was collected to
evaluate the molecular and cellular changes induced by hMSC
administration. First, a group of mice was used to characterize
genome-wide gene expression modulations in the PLv and
Hipp, which contain the neurogenic niches. Principal component
analysis (PCA) showed a distinct global transcriptional profile
in the PLv and Hipp of IR mice, as compared to NonRx
animals, while it was less evident in samples of animals receiving
hMSCs (Figures 3A,B). Gene-expression profiling revealed that
the vast majority of the genes whose expression was significantly
up-regulated (∼81.3%) or down-regulated (∼76.8%) by radiation
or radiation plus hMSCs in each tissue were specific to
the tissue and experimental condition, indicating an overall
distinct expression profile (Figures 3C,D). The analysis of genes
significantly modulated in the comparison IR+MSC versus IR
indicated that 1210 genes were differentially expressed in the
PLv and 1050 in the Hipp (Figures 3E,F and Supplementary
Tables 2, 3). Of these, Calretinin (Calb2), a calcium-binding
protein that plays a role in neuron excitability, was among
the most up-regulated transcripts in the PLv of IR+MSC
mice. The T cell specific GTPase 2 (Tgtp2), a member of
the immune-related p47 GTPases, and the aldehyde oxidase
1 (Aox1), involved in Phase I metabolism of xenobiotics,
were among the most highly over-expressed genes in the
Hipp of IR+MSC mice. Several genes were similarly regulated
in the PLv and Hipp of IR+MSC mice when compared to
IR samples, suggesting that the modulation of these genes
might contribute to the aforementioned improvements in
neurological function after radiation (Figure 3G). Of these,
the down-regulation of the formyl peptide receptor 1 (Fpr1)
was particularly interesting since this gene is a member of
the family of receptors for neutrophil chemotactic factors.
Subsequent analysis using IPA indicated that several pathways
involved in metabolite degradation were significantly modulated
in the PLv of IR+MSC mice when compared to IR mice
(Figure 3H and Supplementary Figures 2, 3). In the Hipp,
the focal adhesion kinase (FAK) signaling, a key regulator of
cell movement, was the most significantly modulated pathway
(Figure 3I and Supplementary Figures 2, 3). Remarkably,
several pathways involved in immune-related processes and
melatonin degradation were altered in both, the PLv and
the Hipp of IR+MSC mice when compared to IR mice
(Figures 3H,I and Supplementary Figures 2, 3). A modulation
of genes involved in immune response and chemotaxis was
also found by Gene Ontology (GO) enrichment analysis using
Database for Annotation, Visualization and Integrated Discovery
(DAVID) (Supplementary Figure 4). The overall interpretation
of these results is that hMSC transplantation modulates genetic





The protective effect of hMSC administration in the PLv and
Hipp 50 days post-radiation (Figure 2D) was further evaluated by
examining CREB signaling, a key mediator of neuroprotection
(Figures 4A–D). We observed a persistent activation of
the transcription factor cAMP response element-binding
(CREB) through phosphorylation at Ser133 in IR mice, which
mediates neuroprotection in brain injury. CREB activation was
accompanied by increased expression of the CREB-binding
protein (CBP), a protein required to initiate transcriptional
regulations mediated by CREB. Interestingly, hMSC treatment
normalized the increased levels of the active isoform of
CREB (PLv: IR+MSC vs. NonIR, p-value = 0.0565; Hipp:
IR+MSC vs. NonIR, p-value = 0.0065). Consistently, the PLv
of IR+MSC mice exhibited lower levels of phosphorylated
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FIGURE 3 | The gene expression profile of the irradiated brains was modulated by hMSC transplantation. (A) PCA of genes expressed in the PLv. Plots represent
individual samples. (B) PCA of genes expressed in the Hipp. Plots represent individual samples. (C) Venn diagrams showing the number and percentage of
significantly up-regulated genes between the different tissues (PLv and Hipp) and different experimental groups (IR vs. NonIR and IR+MSC vs. NonIR). (D) Venn
diagrams showing the number and percentage of significantly down-regulated genes between the different tissues (PLv and Hipp) and different experimental groups
(IR vs. NonIR and IR+MSC vs. NonIR). (E) Volcano plot showing the fold change and statistical significance of genes expressed in the comparison IR+MSC vs. IR in
the PLv. (F) Volcano plot showing the fold change and statistical significance of genes expressed in the comparison IR+MSC vs. IR in the Hipp. (G) Heat map
depicting relative expression levels of shared significantly modulated genes in IR+MSC as compared to IR in PLv and Hipp. (H) Comparison of canonical pathways
significantly altered in the PLv of IR+MSC as compared to IR using the IPA platform. (I) Comparison of canonical pathways significantly altered in the Hipp of
IR+MSC as compared to IR using the IPA platform. n = 3 per group.
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FIGURE 4 | hMSC administration attenuates radiation-induced persistent CREB activation. (A) Western blots showing the activation of CREB signaling in the PLv of
IR mice and partial normalization of CREB expression in IR+MSC mice. (B) Densitometric analysis of the western blots of proteins involved in CREB signaling in the
PLv. Values were normalized to the GAPDH. (C) Western blots showing the activation of CREB signaling in the Hipp of IR mice and partial normalization of CREB
expression in IR+MSC mice. (D) Densitometric analysis of the western blots of proteins involved in CREB signaling in the Hipp. Values were normalized to the
GAPDH. (E) Schematic representation of proteins involved in CREB signaling modulation during radiation and hMSC treatment. Data are represented as
mean ± SEM. n = 4–5 per group. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001; One-way ANOVA.
ERK1/2 at Thr202/Tyr204, a well-known activator of CREB,
when compared to IR mice. In contrast, levels of the Ser9
phospho-inactive isoform of GSK3β, an inhibitor of CREB, were
reduced in the PLv of IR+MSC mice. Interestingly, phospho-Ser9
GSK3β levels in the Hipp were similar between the different
experimental groups, despite the fact that phospho-Ser473
Protein Kinase B (AKT) levels were increased in IR mice, as
compared to the other groups. Furthermore, the brain-derived
neurotrophic factor (BDNF), a downstream target of CREB,
was up-regulated in the Hipp of mice receiving radiation.
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However, MSC treatment did not rescue BNDF levels. Together,
these results indicate that radiation-induced damage response
was down-regulated in IR+MSC mice, suggesting that hMSC
administration promotes brain injury repair, as compared to IR
mice (Figure 4E).
hMSCs Protected From Neural Cell Loss,
Inflammation and Oxidative Stress
To further delineate the effects of hMSC treatment in
irradiated mice, we performed a brain histopathological analysis
(Figure 5A). The neurogenic niches (i.e., SVZ and DG) of
IR and IR+MSC mice exhibited similar levels of Ki67- and
DCX-expressing cells (Figures 5B,C). However, we found that
hMSC treatment preserved the number of NeuN-expressing
cells in the Hipp of irradiated mice (Figure 5D). Cranial
radiation significantly promoted reactive gliosis, as evidenced by
a greater GFAP immunoreactivity, and induced the expression
of activated microglia (CD68 marker) in IR mice, while
transplanted animals exhibited expression levels near NonIR
mice (Figures 5E,F). The number of cells immunoreactive
for iNOS, a classic glial proinflammatory mediator, was also
enhanced in the IR group, while hMSC treatment reverted this
effect (Figure 5G). Plasma levels of IL-2 and IL-1β also support
a normalization of the inflammatory status in transplanted mice
(Supplementary Figure 5).
Protein extracts from the PLv and the Hipp were further
used to evaluate the neuroprotective role of hMSC infusion.
We found that hMSC treatment prevented the elevation of
radiation-induced Caspase 3 expression in the Hipp by western
blot. In contrast, the expression of Caspase 3 in the PLv did not
show differences across the experimental groups (Figures 5H–J).
We determined the oxidative damage by quantifying the
levels of lysine-4-hydroxynonenal (Lys-4-HNE), a marker of
protein-bound lipid peroxidation. The irradiated PLv displayed
increased levels of Lys-4-HNE that were reduced in the PLv
of IR+MSC mice. The reduction of Lys-4-HNE levels in the
Hipp of IR+MSC was less robust (Figures 5J,K). These data
suggest that hMSC administration reduces neuroinflammation,
oxidative damage and neuronal loss in whole-brain irradiated
mice, although it does not prevent neurogenesis decline.
hMSC Administration Does Not
Compromise Survival of Glioma-Bearing
Mice
Finally, we aimed to evaluate whether intranasal delivery of
hMSCs affects life expectancy of brain tumor-bearing mice.
For this, U87 glioma cells were intracranially implanted
into the right striatum of athymic nude mice. Ten days
post-glioma implantation mice received whole-brain radiation
and the following day intranasal administration of hMSCs
was initiated (a dose of cells per week during 4 consecutive
weeks) (Figures 6A,B). All mice exposed to radiation lose
∼15–20% of body weight on the week after irradiation. However,
body weight loss was rapidly recovered, reaching values of
non-irradiated animal (U87 NonIR) by 2-weeks post-irradiation.
During the course of the experiment weight loss prior to
animal death was also observed in all experimental groups
(Figure 6C). Irradiated glioma-bearing mice (i.e., U87 IR and
U87 IR+MSC) exhibited a ∼40% extended median survival
when compared to U87 NonIR mice. Despite median survival
showed no significant differences between U87 IR and U87
IR+MSC, maximal longevity was registered in U87 IR+MSC
mice (Figure 6D). Histopathological analysis of the brain at the
time of death suggested no differences in tumor progression
between groups, as evidenced by hematoxylin and eosin staining
and immunohistochemistry against Ki67 (Figure 6E). These
findings indicate that hMSC treatment does not compromise
survival of mice after oncological radiotherapy.
DISCUSSION
The life expectancy of cancer patients has increased over the
past 10 years due to more effective treatments. However, the
greater effectiveness of these treatments is commonly associated
with a high cost, since patients often face late severe side effects
that significantly limit their quality of life. The majority of brain
tumor patients that receive cranial radiation exhibit cognitive
dysfunction that includes deficits in learning, memory, language,
attention, and executive function (Ali et al., 2018). Here we
demonstrate that the intranasal delivery of hMSCs prevents
late neurofunctional sequelae after radiotherapy in mice. Our
results hold promise in the prevention of radiation-induced
damages in oncological patients to maximize their quality of
life, particularly in pediatric patients whose developing brain is
more radiosensitive.
Seminal reports have shown promising results using stem
cells to prevent radiation-induced damages, although the cells
were intracerebrally or systemically administrated (Acharya et al.,
2009, 2011; Joo et al., 2012; Piao et al., 2015). The intranasal
delivery proposed here is a clinically relevant strategy due to
different aspects. First, the intranasal route is a non-invasive and
feasible method of cell delivery that allows the transplantation of
multiple doses of cells, as compared to intracranial implantation.
Second, therapeutic effectiveness of systemic administration
is hampered by the blood–brain barrier (BBB) (Li et al.,
2015), while the intranasal delivery provides a practical method
that efficiently bypasses the BBB allowing transplanted cells
to reach the brain within minutes to rapidly accomplish
their therapeutic effects (Danielyan et al., 2009). In addition,
nose-to-brain cell delivery uses the olfactory and trigeminal
extracellular pathways to distribute the cells throughout the
central nervous system, thus eliciting effects at multiple sites
within the brain (Thorne et al., 2004; Danielyan et al., 2009).
Accordingly, we found that intranasal administration of hMSCs
improves motor coordination, olfaction and memory, which are
functions coordinated by specific areas located in different parts
of the brain. This represents an advantage over intracerebral
administration, which requires injections at different sites of the
brain to achieve multiple neurofunctional effects. In this regard,
a previous study demonstrated that bilateral injections of hOPCs
into the corpus callosum of rats prevent memory deficits after
radiation, while concomitant transplantation of hOPCs into the
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FIGURE 5 | hMSCs protected from neural cell loss, inflammation and oxidative stress. (A) Immunofluorescence analysis in the brain of NonIR, IR and IR+MSC mice,
using Ki67, DCX, NeuN, GFAP, CD68 and iNOS markers (n = 3–5 per group). (B) Quantification of Ki67 positive cells in the SVZ. (C) Quantification of Ki67 positive
cells in the DG. (D) Quantification of NeuN immunoreactive area in the Hipp. (E) Quantification of the percentage of GFAP immunoreactivity in the striatum.
(F) Quantification of the CD68 immunoreactivity in the cortex. (G) Quantification of iNOS immunoreactivity in the striatum. (H) Densitometric quantification of
Caspase 3 expression by western blot in the PLv. Western blot images are shown in panel (J). (I) Densitometric quantification of Caspase 3 expression by western
blot in the Hipp. Western blot images are shown in panel (J). (J) Representative western blots of Caspase 3 and Lys-4-HNE from PLv and Hipp tissue lysates
(n = 4–5 per group). (K) Densitometric quantification of Lys-4-HNE levels by western blot in PLv and Hipp tissue lysates. Scale bar 25 µm. Data are represented as
mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001; One-way ANOVA (B–I), Two-way ANOVA (K).
cerebellum was necessary to obtain benefits on motor function
(Piao et al., 2015). Finally, our model focuses on the use of hMSCs
derived from the adipose tissue, which represents an interesting
clinical option due to the ease of obtaining large quantities of cells
using a minimally invasive procedure (Lescaudron et al., 2012;
Escacena et al., 2015).
Radiation injury has a multifactorial etiology that includes
vascular damage (Li et al., 2003; Brown et al., 2005),
demyelination (Panagiotakos et al., 2007; Gazdzinski et al.,
2012), inflammation (Hwang et al., 2006), neuronal death, and
neurogenesis decline (Achanta et al., 2012; Capilla-Gonzalez
et al., 2014, 2016). In particular, inflammatory processes
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FIGURE 6 | hMSC administration does not compromise survival of glioma-bearing mice. (A) Schematic representation of the study design. U87 glioma cells were
intracranially transplanted into the striatum of nude mice. After 10 days, mice received whole-brain radiation (total dose of 10 Gy) and the day after, 5 × 105 hMSCs
were administered intranasally once per week for 4 weeks and time of death was monitored. (B) Xenolight DiR-labeled U87 glioma cells were locally transplanted into
the striatum of nude mice. Images show bioluminescence activity in a representative animal 24 h after cell transplantation. (C) Animal weight was measured during
the course of the experiment. Note the weight loss after radiation exposure. (D) Kaplan–Meier curve showing the percentage of survival of glioma-bearing mice. Note
that IR and IR+MSC mice exhibited similar response, increasing survival as compared to NonIR mice. (E) Histological images of brain tumors at the time of death
(indicated as days post tumor implantation, PTI) in the last individual surviving for each experimental group. H&E: Hematoxylin and eosin staining. Scale bar 1 mm
(25 µm for details). Data are represented as mean ± SEM. n = 11–12 per group. ∗p < 0.0001 compared to U87 NonIR mice; Multiple t-test (C), Log-rank test (D).
have been proposed as a major triggering factor leading to
neuropathology in the irradiated brain (Acharya et al., 2016). In
this regard, MSCs are known to exhibit immunomodulatory and
anti-inflammatory properties (Hmadcha et al., 2009; Prockop and
Oh, 2012; Escacena et al., 2015; Fu et al., 2017). Therefore, MSCs
might be the ideal candidate for restoring brain homeostasis in
radiation-induced inflammatory milieu. Here, we found that the
therapeutic application of hMSCs reduces neuroinflammation
and oxidative damage in whole-brain irradiated mice, which
may help to prevent the loss of mature neurons. In contrast,
newly born neurons were not protected by the hMSC treatment.
The study of the neurogenic niche after a longer post-treatment
period of time would be of interest to conclusively determine if
intranasal hMSC delivery rescues irradiation-induced damages
in neurogenesis. Consistently with the histopathological study,
gene expression profiling at long-term evidences a modulation
of neuroprotective processes, such those induced by melatonin
(Mendivil-Perez et al., 2017; Paul et al., 2018), and changes in
immune response pathways in the PLv and the Hipp of IR+MSC
mice. Remarkably, we found a robust long-term activation of
CREB signaling in irradiated mice, which was attenuated in
mice receiving hMSC. In response to injury, CREB coordinates
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expression of genes encoding neuroprotective processes, such as
BDNF that ultimately reduces inflammation, prevents oxidative
damage and promotes anti-apoptotic effects (Han et al., 2000;
Han and Holtzman, 2000). We also observed that both
ERK and GSK3β signaling pathways play an important role
in mediating CREB activation. The overall interpretation of
our data indicates that hMSC transplantation allows a rapid
and efficient repair of radiation-induced damages in mice,
which is reflected in the normalization of neuroprotective
cellular pathways at long-term post-radiation (i.e., 50 days
post-radiation). However, further studies are required to fully
understand the specific mechanisms that hMSCs modulate
to induce radiation-damages repair. Based on our results
and previous studies, we speculate that the beneficial effects
of hMSCs are due to their paracrine activity rather than
neural differentiation of hMSCs (Li et al., 2005; Wakabayashi
et al., 2010; Wu et al., 2018). Extracellular vesicles (EVs)
released by hMSCs are one of the main actors involved
in the paracrine effects by modulating processes such as
immune responses, inflammation, angiogenesis and homeostasis
maintenance (Keshtkar et al., 2018). Indeed, latest research on
regenerative medicine are moving toward cell-free therapies
by employing stem cell-derived EVs due to their reduced
immunogenicity (Zhu et al., 2017). However, obtaining sufficient
amounts of EVs is still a major challenge toward their
clinical application.
The therapeutic application of hMSCs to reduce neurological
complications of radiation could be debatable due to their
potential implications in tumor progression (Shahar et al.,
2017; Whiteside, 2018). However, our pre-clinical study
and others demonstrate that hMSC treatment does not
compromise the survival of rodents with brain tumors
(Balyasnikova et al., 2014; Li et al., 2014; Pacioni et al.,
2017). Indeed, beneficial effects of hMSC administration
have been reported through inhibition of tumor growth in
orthotopic glioblastoma xenografts (Pacioni et al., 2017).
Furthermore, the therapeutic effect of hMSCs to ameliorate
complications associated with cancer treatments is currently
under evaluation in humans. In this line, a Phase I
clinical trial is recruiting patients to evaluate the safety and
feasibility of delivering hMSCs by intracardiac injections
to cancer survivors with cardiomyopathy induced by the
chemotherapeutic anthracycline (NCT02509156). Another
Phase II clinical study is also evaluating the safety and
feasibility of hMSC injections into the submandibular gland to
revert radiation-induced xerostomia in head and neck cancer
patients (NCT02513238).
In conclusion, we demonstrate that intranasally delivered
hMSCs is a non-invasive and effective treatment to promote
brain damage repair after radiation and to improve
neurological function in mice. These results also hold
great promise for other inflammatory disorders, as well
as for those diseases involving cognitive deterioration.
The robust pre-clinical data presented here encourages
the clinical use of hMSCs in cell-based therapy as
an attractive option to prevent side effects induced
by oncological radiotherapy. Despite the therapeutic
window after radiation should be defined in brain
tumor patients, hMSC application to reverse normal
tissue toxicity could become an essential step in their
treatment schedule.
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